BRPI0918851A2 - extrato de tecido adiposo livre de célula, implante, e, métodos para preparar um extrato de tecido adiposo livre de célula, para preparar um implante, e , para induzir adipogênese - Google Patents

extrato de tecido adiposo livre de célula, implante, e, métodos para preparar um extrato de tecido adiposo livre de célula, para preparar um implante, e , para induzir adipogênese

Info

Publication number
BRPI0918851A2
BRPI0918851A2 BRPI0918851A BRPI0918851A BRPI0918851A2 BR PI0918851 A2 BRPI0918851 A2 BR PI0918851A2 BR PI0918851 A BRPI0918851 A BR PI0918851A BR PI0918851 A BRPI0918851 A BR PI0918851A BR PI0918851 A2 BRPI0918851 A2 BR PI0918851A2
Authority
BR
Brazil
Prior art keywords
implant
preparing
adipose tissue
cell free
tissue extract
Prior art date
Application number
BRPI0918851A
Other languages
English (en)
Inventor
Jertta-Riina Sarkanen
Timo Ylikomi
Original Assignee
Jertta-Riina Sarkanen
Timo Ylikomi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jertta-Riina Sarkanen, Timo Ylikomi filed Critical Jertta-Riina Sarkanen
Publication of BRPI0918851A2 publication Critical patent/BRPI0918851A2/pt
Publication of BRPI0918851B1 publication Critical patent/BRPI0918851B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1858—Platelet-derived growth factor [PDGF]
    • A61K38/1866—Vascular endothelial growth factor [VEGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/35—Fat tissue; Adipocytes; Stromal cells; Connective tissues
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/30—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Dispersion Chemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Diabetes (AREA)
  • Biotechnology (AREA)
  • Endocrinology (AREA)
  • Botany (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
BRPI0918851-7A 2008-09-08 2009-09-07 Implante e métodos para preparar um extrato de tecido adiposo livre de célula e para preparar um implante contendo o referido extrato BRPI0918851B1 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US9519808P 2008-09-08 2008-09-08
FI20085839 2008-09-08
US61/095198 2008-09-08
FI20085839A FI20085839A0 (fi) 2008-09-08 2008-09-08 Menetelmiä ja välineitä pehmytkudosteknologiaan
PCT/FI2009/050715 WO2010026299A1 (en) 2008-09-08 2009-09-07 Methods and means for soft tissue engineering

Publications (2)

Publication Number Publication Date
BRPI0918851A2 true BRPI0918851A2 (pt) 2015-12-08
BRPI0918851B1 BRPI0918851B1 (pt) 2019-06-25

Family

ID=39852230

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0918851-7A BRPI0918851B1 (pt) 2008-09-08 2009-09-07 Implante e métodos para preparar um extrato de tecido adiposo livre de célula e para preparar um implante contendo o referido extrato

Country Status (12)

Country Link
US (1) US9056084B2 (pt)
EP (1) EP2337568B1 (pt)
JP (1) JP2012502012A (pt)
CN (1) CN102143755A (pt)
BR (1) BRPI0918851B1 (pt)
DK (1) DK2337568T3 (pt)
ES (1) ES2790300T3 (pt)
FI (1) FI20085839A0 (pt)
LT (1) LT2337568T (pt)
PL (1) PL2337568T3 (pt)
PT (1) PT2337568T (pt)
WO (1) WO2010026299A1 (pt)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3184552B1 (en) 2008-09-02 2020-08-12 Tautona Group LP Threads of hyaluronic acid, methods of making thereof and uses thereof
US20110172180A1 (en) 2010-01-13 2011-07-14 Allergan Industrie. Sas Heat stable hyaluronic acid compositions for dermatological use
JP5719346B2 (ja) 2010-03-04 2015-05-20 味の素株式会社 コーヒーホワイトナー、その製造方法及び飲料の製造方法
HUE043344T2 (hu) 2010-03-22 2019-08-28 Allergan Inc Térhálósított hidrogélek lágy szövet növelésére
GB201007159D0 (en) * 2010-04-29 2010-06-09 Nhs Blood & Transplant Method for evaluating anglogenic potential
US10130736B1 (en) 2010-05-14 2018-11-20 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US8883210B1 (en) 2010-05-14 2014-11-11 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US9352003B1 (en) 2010-05-14 2016-05-31 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US8900571B2 (en) 2010-08-19 2014-12-02 Allergan, Inc. Compositions and soft tissue replacement methods
US8926963B2 (en) 2010-08-19 2015-01-06 Allergan, Inc. Compositions and soft tissue replacement methods
US8894992B2 (en) 2010-08-19 2014-11-25 Allergan, Inc. Compositions and soft tissue replacement methods
EP2675491A2 (en) * 2011-02-17 2013-12-25 Allergan, Inc. Compositions and improved soft tissue replacement methods
US20130096081A1 (en) 2011-06-03 2013-04-18 Allergan, Inc. Dermal filler compositions
US9393263B2 (en) 2011-06-03 2016-07-19 Allergan, Inc. Dermal filler compositions including antioxidants
RU2740454C2 (ru) 2011-06-03 2021-01-14 Аллерган Эндюстри, Сас Составы кожного наполнителя, включая антиоксиданты
US9408797B2 (en) 2011-06-03 2016-08-09 Allergan, Inc. Dermal filler compositions for fine line treatment
EP2726056A4 (en) * 2011-06-28 2015-01-14 Veris Medical Inc SYSTEM AND METHOD FOR COLLAGEN INSULATION
US9662422B2 (en) 2011-09-06 2017-05-30 Allergan, Inc. Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation
US20130244943A1 (en) 2011-09-06 2013-09-19 Allergan, Inc. Hyaluronic acid-collagen matrices for dermal filling and volumizing applications
WO2013106715A1 (en) * 2012-01-13 2013-07-18 Allergan, Inc. Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation
WO2013138864A1 (en) * 2012-03-23 2013-09-26 Neopec Pty Ltd Tissue scaffold
EP2687224A1 (en) * 2012-07-19 2014-01-22 Tissue Med Biosciences Forschungs- und Entwicklungsgesellschaft mbH Medicament for wound treatment
US9867939B2 (en) 2013-03-12 2018-01-16 Allergan, Inc. Adipose tissue combinations, devices, and uses thereof
US20140350516A1 (en) 2013-05-23 2014-11-27 Allergan, Inc. Mechanical syringe accessory
US20150005234A1 (en) * 2013-07-01 2015-01-01 Amit Prakash Govil Soft tissue implant
AU2014296259B2 (en) 2013-07-30 2017-04-27 Musculoskeletal Transplant Foundation Acellular soft tissue-derived matrices and methods for preparing same
US9248384B2 (en) 2013-10-02 2016-02-02 Allergan, Inc. Fat processing system
US10029048B2 (en) 2014-05-13 2018-07-24 Allergan, Inc. High force injection devices
EP3200838B1 (en) 2014-09-30 2019-09-18 Allergan Industrie, SAS Stable hydrogel compositions including additives
JP2018507771A (ja) 2015-03-10 2018-03-22 アラーガン ファーマシューティカルズ ホールディングス （アイルランド） アンリミテッド カンパニー 多針注入器
CA2986702C (en) 2015-05-21 2023-04-04 David Wang Modified demineralized cortical bone fibers
US10912864B2 (en) 2015-07-24 2021-02-09 Musculoskeletal Transplant Foundation Acellular soft tissue-derived matrices and methods for preparing same
US11052175B2 (en) 2015-08-19 2021-07-06 Musculoskeletal Transplant Foundation Cartilage-derived implants and methods of making and using same
RU2725968C2 (ru) 2016-04-08 2020-07-07 Аллерган, Инк. Аспирационно-инъекционное устройство
EP3335696B1 (en) * 2016-12-15 2019-12-18 UPM-Kymmene Corporation A method for drying cell-free tissue extract in a hydrogel comprising nanofibrillar cellulose and a dried hydrogel comprising nanofibrillar cellulose and cell-free tissue extract
IT201700102994A1 (it) * 2017-09-14 2019-03-14 Genlife Sagl Catalizzatore rigenerativo di tessuti e relativo procedimento di realizzazione
CN110496241A (zh) * 2018-05-16 2019-11-26 上海交通大学医学院附属第九人民医院 取自脂肪组织的生物材料及其制备方法和用途
CN112675153A (zh) * 2019-10-17 2021-04-20 上海萨美细胞技术有限公司 无细胞脂肪组织提取物促进毛发生长、固发的用途
CN113398331A (zh) * 2021-05-25 2021-09-17 郑州市和沐生物科技有限公司 无细胞脂肪提取物及其制备方法、分析方法
CN115044541B (zh) * 2022-05-24 2023-08-15 南京农业大学 高分化效率永生猪脂肪前体细胞系及其构建方法与应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4722041B2 (ja) * 2003-06-18 2011-07-13 サイトリ セラピューティクス インコーポレイテッド オートロガス脂肪導入増進における、脂肪組織由来細胞の使用方法
JP2008501724A (ja) * 2004-06-11 2008-01-24 ヴィクトリアン ティッシュ エンジニアリング センター プロプライアトリー リミテッド 組織材料およびマトリックス
JP2008512198A (ja) * 2004-09-08 2008-04-24 ミオカーディアル セラピューティクス インコーポレイティッド 血管新生治療のための自己性または同種性前駆細胞の馴化培地
WO2008041909A1 (en) * 2006-10-02 2008-04-10 Norrfors Searl A method of producing native components, such as growth factors or extracellular matrix proteins, through cell culturing of tissue samples for tissue repair
EP2252686B1 (en) * 2008-02-11 2017-10-11 The Johns Hopkins University Compositions and methods for implantation of adipose tissue and adipose tissue products

Also Published As

Publication number Publication date
PL2337568T3 (pl) 2020-08-10
JP2012502012A (ja) 2012-01-26
DK2337568T3 (da) 2020-05-11
CN102143755A (zh) 2011-08-03
FI20085839A0 (fi) 2008-09-08
ES2790300T3 (es) 2020-10-27
EP2337568A4 (en) 2014-02-19
WO2010026299A1 (en) 2010-03-11
BRPI0918851B1 (pt) 2019-06-25
PT2337568T (pt) 2020-05-15
LT2337568T (lt) 2020-05-25
EP2337568B1 (en) 2020-02-19
US9056084B2 (en) 2015-06-16
US20110151005A1 (en) 2011-06-23
EP2337568A1 (en) 2011-06-29

Similar Documents

Publication Publication Date Title
BRPI0918851A2 (pt) extrato de tecido adiposo livre de célula, implante, e, métodos para preparar um extrato de tecido adiposo livre de célula, para preparar um implante, e , para induzir adipogênese
HRP20171471T1 (hr) Uređaj za pripremu tkiva, posebno masnog tkiva
IL247717A (en) Medical device for surgical implantation
BR112013006288A2 (pt) dispositivo de colocação para uma válvula cardíaca protética colapsável, e, método para colocar uma válvula cardíaca protética colapsável em um paciente
BRPI0908087A2 (pt) Composições e métodos para implante de tecido adipose e produtos de tecido adiposo
HK1206651A1 (en) Implant for tissue engineering
BR112013002765A2 (pt) implante deflectível, sistema e métodos para implantação do mesmo
BRPI1012148A2 (pt) método e equipamento para preparar dentadura
BR112013032134A2 (pt) fibra de aposição para uso em implantação andoluminal de implantes expansíveis
BR112012003092A2 (pt) composições e métodos para implantação de tecido adiposo processado e produtos de tecido adiposo processados.
BR112013016226A2 (pt) dispositivo de sutura, método de uso de um dispositivo de sutura e material de sutura de tecido
HK1177411A1 (zh) 用於將假體植入到組織中的裝置
DK2248488T3 (da) Anterior stabiliseret knæimplantat
BRPI0911078A2 (pt) sistema e método para a projetar e formar um implante cirúrgico
BRPI0910969A2 (pt) dispositivo, método para preparar em dispositivo, e, método para tratar um paciente
BR112012004178A2 (pt) implemento para cuidado oral, e, aparelho para um implemento oral
BRPI0817299A2 (pt) Vacinas e componentes de vacina para inibição de células microbianas
BRPI0922174A2 (pt) preparação farmacêutica, uso de uma preparação, e, método para preparar uma preparação farmacêutica
BRPI0822920A2 (pt) Implante médico e método de implantação
BRPI0817198A2 (pt) (ciclopropilfenil)feniloxalamidas, método para a produção das mesmas, e uso das mesmas como um medicamento
DK2316382T3 (da) Protese til ucementeret fiksering
BRPI1013089A2 (pt) alimento medicinal, e, métodos para preparar um alimento medicinal, e para tratar um distúrbio metabólico
EP2129337A4 (en) IMPLANT SAVING FABRICS
BRPI0920138A2 (pt) lente intraocular, e, métodos para fabricar uma lente intraocular, e para inserir uma lente intraocular em um paciente
BR112012001998A2 (pt) solução oftálmica, uso de um composto, e, método para preparação de uma solução oftálmica.

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 07/09/2009, OBSERVADAS AS CONDICOES LEGAIS. (CO) 20 (VINTE) ANOS CONTADOS A PARTIR DE 07/09/2009, OBSERVADAS AS CONDICOES LEGAIS